Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages

ABSTRACT We investigated the ability of using monoclonal antibodies (MAbs) against anthrax protective antigen (PA), an anthrax exotoxin component, to modulate exotoxin cytotoxic activity on target macrophage cell lines. Anthrax PA plays a critical role in the pathogenesis of Bacillus anthracis infection. PA is the cell-binding component of the two anthrax exotoxins: lethal toxin (LeTx) and edema toxin. Several MAbs that bind the PA component of LeTx are known to neutralize LeTx-mediated killing of target macrophages. Here we describe for the first time an overlooked population of anti-PA MAbs that, in contrast, function to increase the potency of LeTx against murine macrophage cell lines. The results support a possible mechanism of enhancement: binding of MAb to PA on the macrophage cell surface stabilizes the PA by interaction of MAb with macrophage Fcγ receptors. This results in an increase in the amount of PA bound to the cell surface, which in turn leads to an enhancement in cell killing, most likely due to increased internalization of LF. Blocking of PA-receptor binding eliminates enhancement by MAb, demonstrating the importance of this step for the observed enhancement. The additional significance of these results is that, at least in mice, immunization with PA appears to elicit a poly-clonal response that has a significant prevalence of MAbs that enhance LeTx-mediated killing in macrophages.

[1]  P. Hanna,et al.  Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. , 1992, Molecular biology of the cell.

[2]  S. E. Hammond,et al.  Lethal Factor Active-Site Mutations Affect Catalytic Activity In Vitro , 1998, Infection and Immunity.

[3]  T. Manser,et al.  Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. , 2000, Journal of immunology.

[4]  S. Leppla,et al.  Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin , 1990, Infection and immunity.

[5]  John A. Young,et al.  Identification of the cellular receptor for anthrax toxin , 2001, Nature.

[6]  S. Leppla,et al.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Shinji Watanabe,et al.  Infectivity-Enhancing Antibodies to Ebola Virus Glycoprotein , 2001, Journal of Virology.

[8]  S. Leppla.  Production and purification of anthrax toxin. , 1988, Methods in enzymology.

[9]  T. Hohdatsu,et al.  The role of IgG subclass of mouse monoclonal antibodies in antibody-dependent enhancement of feline infectious peritonitis virus infection of feline macrophages , 2005, Archives of Virology.

[10]  R. Collier,et al.  Protective antigen‐binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino‐ or carboxy‐terminus , 1995, Molecular microbiology.

[11]  K. Klimpel,et al.  Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  K. Wolff,et al.  Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro. , 1996, Journal of immunology.

[13]  S. Leppla.  Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. , 1984, Advances in cyclic nucleotide and protein phosphorylation research.

[14]  M. Mock,et al.  Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. , 1998, Biochemical and biophysical research communications.

[15]  P. Parren,et al.  The IgG Fc Contains Distinct Fc Receptor (FcR) Binding Sites: The Leukocyte Receptors FcγRI and FcγRIIa Bind to a Region in the Fc Distinct from That Recognized by Neonatal FcR and Protein A1 , 2000, The Journal of Immunology.

[16]  J. Unkeless.  Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors , 1979, The Journal of experimental medicine.

[17]  C. B. Thorne,et al.  RAPID LETHAL EFFECT IN RATS OF A THIRD COMPONENT FOUND UPON FRACTIONATING THE TOXIN OF BACILLUS ANTHRACIS , 1962, Journal of bacteriology.

[18]  M. J. Rosovitz,et al.  Alanine-scanning Mutations in Domain 4 of Anthrax Toxin Protective Antigen Reveal Residues Important for Binding to the Cellular Receptor and to a Neutralizing Monoclonal Antibody* , 2003, Journal of Biological Chemistry.

[19]  J. Kirby.  Anthrax Lethal Toxin Induces Human Endothelial Cell Apoptosis , 2004, Infection and Immunity.

[20]  Y. Kawaoka,et al.  Antibody-Dependent Enhancement of Ebola Virus Infection , 2003, Journal of Virology.

[21]  Emiko Mizoguchi,et al.  MHC Class I-Related Neonatal Fc Receptor for IgG Is Functionally Expressed in Monocytes, Intestinal Macrophages, and Dendritic Cells1 , 2001, The Journal of Immunology.

[22]  T. Manser,et al.  Fcγ Receptor IIB on Follicular Dendritic Cells Regulates the B Cell Recall Response1 , 2000, The Journal of Immunology.

[23]  Bali Pulendran,et al.  Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin , 2003, Nature.

[24]  R. Liddington,et al.  Crystal structure of the anthrax toxin protective antigen , 1997, Nature.

[25]  Shihui Liu,et al.  Cell Surface Tumor Endothelium Marker 8 Cytoplasmic Tail-independent Anthrax Toxin Binding, Proteolytic Processing, Oligomer Formation, and Internalization* , 2003, The Journal of Biological Chemistry.

[26]  J S Wall,et al.  Anthrax protective antigen forms oligomers during intoxication of mammalian cells. , 1994, The Journal of biological chemistry.

[27]  P. Beverley,et al.  T cell activation by anti‐T3 antibodies: Comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors , 1986, European journal of immunology.

[28]  K. Klimpel,et al.  Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity , 1994, Molecular microbiology.

[29]  S. Leppla,et al.  Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin , 1988, Infection and immunity.

[30]  K. Yoon,et al.  Antibody-dependent enhancement of virus infection and disease. , 2003, Viral immunology.

[31]  H. Smith,et al.  Purification of factor I and recognition of a third factor of the anthrax toxin. , 1961, Journal of general microbiology.

[32]  R. Kimberly,et al.  Receptors for immunoglobulin G. Molecular diversity and implications for disease. , 1995, Arthritis and rheumatism.

[33]  J. Alouf.  Bacterial Protein Toxins , 2000 .

[34]  B. Bloom,et al.  Role of Macrophage Oxidative Burst in the Action of Anthrax Lethal Toxin , 1994, Molecular medicine.

[35]  D. Conrad,et al.  A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation. , 1997, International immunology.

[36]  K D Paull,et al.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. , 1998, Science.

[37]  D. Acosta,et al.  On the role of macrophages in anthrax. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Collier,et al.  Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells , 1991, Infection and immunity.

[39]  W. Ribot,et al.  Fermentation, Purification, and Characterization of Protective Antigen from a Recombinant, Avirulent Strain ofBacillus anthracis , 1998, Applied and Environmental Microbiology.

[40]  J. Mackenzie,et al.  Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice. , 2003, The Journal of general virology.

[41]  M. Hansen,et al.  Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.

[42]  A. Friedlander,et al.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. , 1986, The Journal of biological chemistry.

[43]  Michael Karin,et al.  Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition , 2002, Science.

[44]  M. Mock,et al.  Contribution of individual toxin components to virulence of Bacillus anthracis , 1991, Infection and immunity.